The GLP is committed to full transparency. Download and review our Annual Report.

Human Genome Project pioneer now on a quest to solve chronic fatigue syndrome

| | May 17, 2019

[Ron] Davis, who is 77, leads a lab that invented much of the technology that powered the Human Genome Project. Now he and his wife spend much of their days caring for their 35-year-old son, who is immobilized by myalgic encephalomyelitis, or chronic fatigue syndrome (ME/CFS).

Davis is leading a global push to root out the molecular basis of what is laying waste to Whitney.

One of their inventions, a “nanoneedle” for testing blood, speaks to the need to find a single biomarker in patients’ blood.

Davis’ team has tested their nanoneedle with initial success and recently published their findings in a scholarly journal. They discovered ME/CFS patients’ blood responds to the introduction of “stress” — in this case, salt — differently than the blood of healthy people. Davis hopes the device will ultimately produce a cheap clinical test by which doctors can identify ME/CFS quickly and accurately.

Related article:  Using genetics and social media to find answers for rare 'undiagnosed' diseases

He also wants to explore measures to prevent the disease. For example, he wants to understand why people with mononucleosis often develop ME/CFS.

Those are just a few of many things Davis’ team are working on.

Read full, original post: He pioneered technology that fueled the Human Genome Project. Now his greatest challenge is curing his own son

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend